Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also provided guidance for fiscal 2022.
The Indianapolis-based pharmaceutical company said its revenues moved up 2% year-over-year to $6.94 billion in the third quarter as worldwide volumes increased by 13%.
The positive top-line performance translated into a 12% increase in net earnings, on an adjusted basis, to $1.98 per share. Unadjusted profit increased to $1.45 billion or $1.61 per share from $1.11 billion or $1.22 per share in the third quarter of 2021.
Check this space to read management/analysts’ comments on Eli Lilly’s Q3 2022 earnings
“With four more launches expected by the end of next year and a potential major new indication for tirzepatide, Lilly continues to make progress for patients with unaddressed medical needs through our significant commitment to invest in R&D, welcome the best talent, and turn breakthroughs in our labs into medicines for people around the world,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
Important takeaways from IBM’s first-quarter 2024 earnings report
International Business Machines Corporation (NYSE: IBM) this week reported mixed results for the first three months of fiscal 2024, with earnings beating and revenues missing analysts’ estimates. After spinning off
Snap (SNAP): Four noteworthy points from the Q1 earnings report
Shares of Snap Inc. (NYSE: SNAP) jumped 30% on Friday, a day after the company delivered strong results for the first quarter of 2024. Revenue and earnings increased year-over-year and
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or